IDEC-C2B8 ANTI-CD20 ANTIBODY - FINAL REPORT ON A PHASE-III PIVOTAL TRIAL IN PATIENTS (PTS) WITH RELAPSED LOW-GRADE OR FOLLICULAR LYMPHOMA (LG F NHL)/

MCLAUGHLIN P CABANILLAS F GRILLOLOPEZ AJ LINK BK LEVY R CRUCZMAN M HEYMAN MR WILLIAMS M JAIN W BENCEBRUCKLER I HO AD LISTER J ROSENBERG J DALLAIRE BK SHEN D

P. Mclaughlin et al., IDEC-C2B8 ANTI-CD20 ANTIBODY - FINAL REPORT ON A PHASE-III PIVOTAL TRIAL IN PATIENTS (PTS) WITH RELAPSED LOW-GRADE OR FOLLICULAR LYMPHOMA (LG F NHL)/, Blood, 88(10), 1996, pp. 349-349

NO

Hematology

Blood → ACNP

00064971

88

10

1996

1

1

349 - 349

ISI

0006-4971(1996)88:10<349:IAA-FR>2.0.ZU;2-M